31st Hemophilia Symposium

Hamburg 2000

Häftad, Engelska, 2001

Av I. Scharrer, W. Schramm, I. Scharrer, W. Schramm

1 459 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This book contains the contributions to the 31st Hemophilia Symposium, 2000. The main topics are epidemiology, inhibitors in hemophilia, therapy and monitoring of bleeds in acute and intensive care medicine, and pediatric hemostasiology. The volume is rounded off by numerous free papers and posters on hemophilia, hemorrhagic diathesis, thrombophilic diathesis and associated topics.

Produktinformation

Utgivningsdatum2001-10-23
Mått155 x 235 x 18 mm
Vikt487 g
FormatHäftad
SpråkEngelska
Antal sidor287
FörlagSpringer-Verlag Berlin and Heidelberg GmbH & Co. KG
ISBN9783540421313

Tillhör följande kategorier

Smärta och smärtbehandling inom Medicin
Pediatrik inom Medicin
Olycksfalls- och akutmedicin inom Medicin
Hematologi inom Medicin

Presentation of the Johann-Lukas-Schoenlein-Award.- I. Epidemiology.- HIV Infection and Causes of Death in Patients with Hemophilia in Germany (Year 1999/2000 Survey).- Hemophilia 2000 — the Annual Survey of the Austrian Hemophilia Centers.- II. Inhibitors in Hemophilia.- Changes in Epitope Specificity and in Distribution of FVIII Antibodies during Immune Tolerance Therapy (ITT) in Hemophilia A Patients with FVIII Antibodies — a Case Report.- Clinical Experience with the Modified Bonn-Malmö Protocol since 1996.- Course of Inhibitors in mild Hemophilia A with and without Immune Tolerance Treatment.- III. Therapy and Monitoring of Bleeds in Acute- and Intensive Care Medicine.- Management of Bleeding in Surgery and Intensive Care.- IV.. Pediatric Hemostaseology.- Frequency and Profile of viral posttransfusional Infections in Patients from Hemophilia Center Timisoara.- Symptomatic Onset of severe Hemophilia A in Childhood is dependent on the Presence of Prothrombotic Risk Factors.- Differences between Neonates and Adults in Plasmin Inhibitory and Antifibrinolytic Action of Aprotinin.- Shorter PFA-100 Closure Times (CT) in Neonates than in Adults: Role of Red Cells, White Cells, Platelets, and von Willebrand Factor.- V. Free Lectures.- Efficacy and Safety of a High Purity Protein C Concentrate in the Management of Patients with severe Congenital Protein C Deficiency.- Respective Roles of Factors II, VII, IX, and X in the Procoagulant Activity of FEIBA.- Capillary Microscopic and Rheological Dimensions for the Diagnosis of von-Willebrand-Disease in Comparison with other Hemorrhagic Diatheses.- Evaluation of Denaturing High Performance Liquid Chromatography (DHPLC) in the Analysis of Hemophilia A.- Vla. Poster: Clinic and Casuistic.- Rheumatoid Arthritis in a Patient withHemophilia Arthropathy — a Case Report.- Recurrent Fatal Intracranial Hemorrhage (ICH) in Two Non-Identical Twins suffering from Hemophilia B (Factor IX Activity < 1%).- Progression of Thrombosis under Low Molecular Weight Heparin without Heparin-Induced Thrombocytopenia in a young Man: a Case Report.- Cardiac Tamponade in a Patient with acquired Factor VIII Inhibitor and Chronic Renal Failure.- Endoscopic Cholecystectomy in a 55-year-old Patient with Heparin-Induced Thrombocytopenia Type II and Replacement of Mitral and Aortic Valve and Tricuspidal Valve Anular Plasty.- Vlb. Poster: Hemophilia.- Successful Orthopedic Operations in Hemophilic Adults with Inhibitors against Factor VIII.- Evaluation of Clinical Efficacy of rFVIIa in Pediatrics.- Risk Factors for Thrombosis in Hemophilia — an Analysis.- Status of Pain in Patients with severe Haemophilic Arthropathies.- Results of a 5-year Clinical Study with a B-domain Deleted FVIII Concentrate (rFVIII-SQ).- Outpatient Treatment with Radiosynoviorthesis in Hemophilic Arthropathy.- Requirements for Future Hemophilia Treatment from the Patients’ Point of View.- Vic. Poster: Hemorrhagic Diathesis.- Molecular Basis of von Willebrand Disease Type IIC Miami.- Hemorrhagic Diathesis through acquired Factor XIII Inhibitor.- Liver Transplantation in a Patient with severe von Willebrand Disease Type 3: Levels of von Willebrand Factor Following Transplantation.- Clincal Course and Laboratory Findings in a Patient with a New Mutation Causing Wiskott-Aldrich Syndrome.- Role of acquired and inherited Prothrombotic Risk Factors in Pediatric Cerebral Venous Thrombosis — Preliminary Results of a Multicenter Case-Control Study.- Analysis of the Fibrinogen Genes of 40 Patients with Suspicion of Dys-, Hypo- or Afibrinogenemia.- Vld.Poster: Thrombophilic Diathesis.- Hereditary Antithrombin Deficiency — Results of a Family Study.- Elevated Factor IX and Factor XI as Risk Factors for Venous Thrombosis and Stroke.- Thrombophilic Risk Parameters in Juvenile »Idiopathic« Stroke Patients.- Inquiry into the Significance of Constantly Raised FVIII Values as a Factor in Thrombophilia.- Do Statins Increase the Homocysteine Level?.- Alpha 2-Macroglobulin Level regulates the Anticoagulant Cofactor Activity of Protein S in Cord and Adult Plasma.- Combined Prothrombotic Defects and Contraceptives — Risk Factor for Deep Venous Thrombosis in Adolescence.- Role of 23 bp Insertion in Exon 3 of the Endothelial Cell Protein C Receptor Gene in Venous Thrombophilia.